Lorynn Teela

278 Chapter 9 20. Glenwright BG, Simmich J, Cottrell M, O’Leary SP, Sullivan C, Pole JD, et al. Facilitators and barriers to implementing electronic patient-reported outcome and experience measures in a health care setting: a systematic review. Journal of patient-reported outcomes. 2023;7(1):13. 21. Stover AM, Haverman L, van Oers HA, Greenhalgh J, Potter CM, van IPPiCPISWGSAJGEGLHKMCPNRMSAMSH. Using an implementation science approach to implement and evaluate patient-reported outcome measures (PROM) initiatives in routine care settings. Quality of Life Research. 2021;30:3015-33. 22. Antunes B, Harding R, Higginson IJ, Euroimpact. Implementing patient-reported outcome measures in palliative care clinical practice: a systematic review of facilitators and barriers. Palliative medicine. 2014;28(2):158-75. 23. Greenhalgh J, Dalkin S, Gooding K, Gibbons E, Wright J, Meads D, et al. Functionality and feedback: a realist synthesis of the collation, interpretation and utilisation of patient-reported outcome measures data to improve patient care. Health Services and Delivery Research. 2017;5(2):1-280. 24. van Egdom LS, Oemrawsingh A, Verweij LM, Lingsma HF, Koppert LB, Verhoef C, et al. Implementing patient-reported outcome measures in clinical breast cancer care: a systematic review. Value in Health. 2019;22(10):1197-226. 25. Foster A, Croot L, Brazier J, Harris J, O’Cathain A. The facilitators and barriers to implementing patient reported outcome measures in organisations delivering health related services: a systematic review of reviews. Journal of patient-reported outcomes. 2018;2(1):1-16. 26. Powell BJ, Waltz TJ, Chinman MJ, Damschroder LJ, Smith JL, Matthieu MM, et al. A refined compilation of implementation strategies: results from the Expert Recommendations for Implementing Change (ERIC) project. Implementation science. 2015;10(1):1-14. 27. CFIR-ERIC Matching Tool v1.0. 2019 [Available from: https://cfirguide.org/choosing-strategies/. 28. Morena AL, Gaias LM, Larkin C. Understanding the Role of Clinical Champions and Their Impact on Clinician Behavior Change: The Need for Causal Pathway Mechanisms. Frontiers in Health Services. 2022;2:896885. 29. Maud M. van Muilekom HAvO, Ellen M. Smets, Lorynn Teela, Martha A. Grootenhuis, Lotte Haverman. Supporting pediatric patients and parents in discussing Patient Reported Outcomes with their clinician in clinical practice: the development of online tools. Submitted. 30. Klaufus L, Luijten M, Verlinden E, Van der Wal M, Haverman L, Cuijpers P, et al. Psychometric properties of the Dutch-Flemish PROMIS® pediatric item banks Anxiety and Depressive Symptoms in a general population. Quality of Life Research. 2021;30(9):2683-95. 31. Luijten MA, van Litsenburg RR, Terwee CB, Grootenhuis MA, Haverman L. Psychometric properties of the Patient-Reported Outcomes Measurement Information System (PROMIS®) pediatric item bank peer relationships in the Dutch general population. Quality of Life Research. 2021;30:2061-70. 32. Kallen MA, Cook KF, Amtmann D, Knowlton E, Gershon RC. Grooming a CAT: customizing CAT administration rules to increase response efficiency in specific research and clinical settings. Quality of Life Research. 2018;27:2403-13. 33. Luijten MAJ. Standardizing patient-reported outcome measurement in pediatrics: Validation & implementation of PROMIS. Amsterdam: University of Amsterdam; 2022. 34. Stor MLE, Lokhorst MM, Horbach SER, Young-Afat DA, Spuls PI, van der Horst C. Appearancerelated concerns and their impact on health-related quality of life in patients with peripheral vascular malformations. J Plast Reconstr Aesthet Surg. 2022;75(11):4202-11. 35. Bense JE, Haverman L, von Asmuth EGJ, Louwerens M, Luijten MAJ, Stiggelbout AM, et al. Late Effects in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation for Nonmalignant Diseases: Proxy- and Patient-Reported Outcomes. Transplant Cell Ther. 2023;29(3):186.e1-.e10. 36. Dovern E, Nijland S, van Muilekom MM, Suijk LMJ, Hoogendoorn GM, Mekelenkamp H, et al. Physical, Mental, and Social Health of Adult Patients with Sickle Cell Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Mixed-Methods Study. Transplant Cell Ther. 2023;29(4):283.e1-.e9. 37. van Muilekom MM, Luijten MAJ, van Oers HA, Terwee CB, van Litsenburg RRL, Roorda LD, et al. From statistics to clinics: the visual feedback of PROMIS® CATs. J Patient Rep Outcomes. 2021;5(1):55.

RkJQdWJsaXNoZXIy MTk4NDMw